ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,080.31
0.19%
US Tech 100
17,136.40
0.79%
Dow Jones
38,490.71
-0.03%
Brent Oil
87.205
-0.41%
Bitcoin
66,109.31
-0.45%
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
04/24/202410:13AMBusiness WireT-Mobile Unveils BIG Moves to Help Small Businesses GrowNASDAQ:TMUST Mobile US Inc
04/24/202410:11AMGlobeNewswire Inc.Fulcrum GT Renews Its Commitment to Els for Autism Foundation
04/24/202410:11AMGlobeNewswire Inc.Crédit Mutuel Home Loan SFH - Communiqué de mise à disposition du Rapport financier annuel 2023
04/24/202410:10AMGlobeNewswire Inc.Meet Our Nation’s Next Generation of Leaders, Volunteer at FBLA
04/24/202410:10AMBusiness WireHilton Grand Vacations Unveils 2024 Brand Ambassadors to Headline Exclusive Member ExperiencesNYSE:HGVHilton Grand Vacations Inc
04/24/202410:10AMBusiness WireSheppard Mullin Welcomes IP Partner Alex Chung in Washington D.C.
04/24/202410:10AMPR Newswire (US)Global Distribution Transformer Market to Reach $47.5 billion, Globally, by 2033 at 6.6% CAGR: Allied Market Research
04/24/202410:10AMPR Newswire (US)Global Distribution Transformer Market to Reach $47.5 billion, Globally, by 2033 at 6.6% CAGR: Allied Market Research
04/24/202410:10AMPR Newswire (US)Breakthrough in Lung Cancer Treatment: Dizal to Unveil Groundbreaking Results of Sunvozertinib for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations at 2024 ASCO Annual Meeting
04/24/202410:10AMBusiness WireNature Publication Highlights the Benefits of Tropis® Intradermal When Used to Administer a First-in-Class Self-Amplifying mRNA Vaccine
04/24/202410:09AMGlobeNewswire Inc.Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024NASDAQ:CGEMCullinan Therapeutics Inc
04/24/202410:08AMGlobeNewswire Inc.Blue Island Homes Chosen as Exclusive Listing Brokers for Ocean Watch at Harbor Pointe: A Premier Gated Waterfront Living Experience in Freeport, New York
04/24/202410:07AMPR Newswire (US)American Association of Critical-care Nurses Publishes Specialty's First Standards for Appropriate Staffing
04/24/202410:07AMPR Newswire (US)GRAINGER INCREASES QUARTERLY DIVIDEND BY 10%; REFRESHES SHARE REPURCHASE AUTHORIZATIONNYSE:GWWWW Grainger Inc
04/24/202410:05AMGlobeNewswire Inc.Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCONASDAQ:REGNRegeneron Pharmaceuticals Inc
04/24/202410:05AMGlobeNewswire Inc.Volvo Trucks North America Continues ‘Toward Zero’ by Fueling All New Trucks with HVO at the New River Valley Plant
04/24/202410:05AMBusiness WireRiemer & Braunstein Announces Promotions
04/24/202410:05AMBusiness WireHighField Biopharmaceuticals Announces Two Abstracts Accepted for the 2024 ASCO Annual Meeting
04/24/202410:05AMBusiness WireEasyKnock Announces Partnership With Piñata
04/24/202410:05AMGlobeNewswire Inc.Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual MeetingTSX:MDNAMedicenna Therapeutics Corp
04/24/202410:05AMGlobeNewswire Inc.Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:HOWLWerewolf Therapeutics Inc
04/24/202410:05AMBusiness WireAlliant Insurance Services Welcomes Esther Magner as Vice President and Producer for Employee Benefits Group
04/24/202410:05AMPR Newswire (US)Duke Energy's annual Impact Report shares progress toward a cleaner tomorrow that includes affordability and reliabilityNYSE:DUKDuke Energy Corp New
04/24/202410:05AMBusiness WireBicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual MeetingNASDAQ:BCYCBicycle Therapeutics PLC
04/24/202410:05AMPR Newswire (US)Onward Search Wins ClearlyRated's 2024 Best of Staffing Awards
04/24/202410:05AMPR Newswire (US)IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored StudyNASDAQ:IDYAIDEAYA Biosciences Inc
04/24/202410:05AMPR Newswire (Canada)REMBRANDT - Etchings from the Boijmans Van Beuningen - A great master of the Dutch Golden Age is honoured in Québec City
04/24/202410:04AMBusiness WireBayer Introduces Iberogast™ in the U.S., Bringing Proven Plant-Based Relief to the Millions Who Experience Gut Health Issues
04/24/202410:04AMPR Newswire (US)BitIRA Launches Self-Service Bitcoin IRA Platform
04/24/202410:03AMBusiness WireLegacy Brokerage and Marketing Redefines Brokerage Standards with Innovative Approach

Your Recent History

USOTC
ASKH
Astika (PK)
NASDAQ
TSLA
Tesla
USOTC
BLLB
Bell Buckle (PK)
NASDAQ
SBFM
Sunshine Biopharma
USOTC
PSRU
Valiant Eagle (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
NASDAQ
AGBA
AGBA
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
NLST
Netlist (QB)
USOTC
FBEC
FBEC Worldwide (PK)
USOTC
MGON
Megola (PK)
NASDAQ
COOP
Mr Cooper
USOTC
DRNK
NoHo (PK)
USOTC
RONN
Ronn Motor (PK)
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved